Shares of Novavax Inc. NVAX, -1.24% shed 1.24% to $155.84 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, +0.26% rising 0.26% to 36,398.21 and the NASDAQ Composite Index COMP, -0.56% falling 0.56% to 15,781.72. This was the stock’s sixth consecutive day of losses. Novavax Inc. closed $175.84 below its 52-week high ($331.68), which the company achieved on February 9th.
Despite its losses, the stock outperformed some of its competitors Tuesday, as Replimune Group Inc. REPL, -2.30% fell 2.30% to $27.19, VBI Vaccines Inc. VBIV, -4.33% fell 4.33% to $2.21, and AnaptysBio Inc. ANAB, -1.56% fell 1.56% to $35.93.true Trading volume (12.3 M) eclipsed its 50-day average volume of 5.9 M.